research » Trang Công Nghệ | Trangcongnghe.vn

BASF Agricultural Solutions successfully commissions new fermentation plant for crop protection products in Ludwigshafen

Globe Newswire

BASF Agricultural Solutions successfully commissions new fermentation plant for crop protection products in Ludwigshafen

Globenewswire -

Boehringer Ingelheim delivers on late-stage pipeline with two key launches, grows sales by 7.3%* in a successful 2025

Globe Newswire

Boehringer Ingelheim delivers on late-stage pipeline with two key launches, grows sales by 7.3%* in a successful 2025

Globenewswire -

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation

Globe Newswire

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation

Globenewswire -

Wood Mackenzie harnesses AI-powered analytics to decode complex energy market interconnections

Globe Newswire

Wood Mackenzie harnesses AI-powered analytics to decode complex energy market interconnections

Globenewswire -

Nearfield Instruments and Singapore’s A*STAR IME Sign Research Collaboration Agreement to Advance Semiconductor Metrology Solutions for AI and Advanced Packaging Era

Globe Newswire

Nearfield Instruments and Singapore’s A*STAR IME Sign Research Collaboration Agreement to Advance Semiconductor Metrology Solutions for AI and Advanced Packaging Era

Globenewswire -

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Globe Newswire

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Globenewswire -

Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer

Globe Newswire

Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer

Globenewswire -

XEM THÊM TIN MỚI